|
Originally published In Press as doi:10.1074/jbc.M205152200 on June 12, 2002
J. Biol. Chem., Vol. 277, Issue 36, 32562-32570, September 6, 2002
The Expression of Free Oligosaccharides in Human Seminal
Plasma*
Sara
Chalabi ,
Richard L.
Easton ,
Manish S.
Patankar§,
Frank
A.
Lattanzio§,
Jamie C.
Morrison§,
Maria
Panico ,
Howard R.
Morris ¶,
Anne
Dell , and
Gary F.
Clark§**
From the Department of Biological Sciences, Imperial
College of Science, Technology, and Medicine,
London SW7 2AY, United Kingdom and § Department of
Physiological Sciences, Eastern Virginia Medical School,
Norfolk, Virginia 23501-1980
Received for publication, May 24, 2002, and in revised form, June 12, 2002
 |
ABSTRACT |
Human seminal plasma is a complex mixture of
proteins, glycoproteins, peptides, glycopeptides, and prostaglandins
secreted by organs of the male reproductive tract. The components of
this fluid have been implicated in the suppression of immune response, agonistic effects on sperm-egg binding, and promotion of successful implantation of the human embryo. Fractionation followed by biophysical analyses revealed that free oligosaccharides constitute a major component of the total glycoconjugates within seminal plasma. Significant findings of our analyses include the following: (i) the
concentration of free oligosaccharides is 0.3-0.4 mg/ml; (ii) mono-
and difucosylated forms of the disaccharide lactose are major
components; (iii) many of the remaining oligosaccharides are also rich
in fucose and carry Lewisx and/or Lewisy
epitopes; (iv) a subset of the oligosaccharides express the reducing end sequence (GlcNAc 1-3/4Glc) not reported in human milk
oligosaccharides; (v) oligosaccharides in seminal plasma exclusively
express type 2 (Gal 1-4GlcNAc) but not the type 1 sequences
(Gal 1-3GlcNAc) that predominate in human milk glycans; and (vi) the
structural diversity of seminal plasma oligosaccharides is far less
than human milk oligosaccharides. The agonistic effect of both fucose and fucosylated glycoconjugates on human sperm-egg binding in vitro suggests that fucosylated oligosaccharides may also promote fertilization in the female reproductive tract.
 |
INTRODUCTION |
Human semen contains a variety of different cell types including
sperm, neutrophils, monocytes, and lymphocytes (reviewed in Ref. 1). If
incubated for a brief period of time, semen undergoes a process known
as liquefaction that leads to clearing of this fluid and a partial loss
of its viscosity (2). Centrifugation of partially liquefied semen leads
to the separation of the cellular components from the viscous acellular
fluid known as human seminal plasma
(HSP).1
HSP is more than simply a liquid medium for transporting sperm into the
vagina. It is an extremely complex mixture of proteins, glycoproteins,
peptides, glycopeptides, and prostaglandins secreted by the organs
of the male reproductive tract (reviewed in Ref. 1). A plethora of
different studies indicate that HSP supports sperm function, modulates
maternal immune responses directed against sperm, and promotes
successful implantation of the human embryo (reviewed in Refs. 1, 3,
and 4). The components of HSP may therefore profoundly impact male
fertility in the female reproductive tract.
Previous studies confirm that HSP contains a specific glycoprotein with
immunomodulatory activities (5) now known as glycodelin-S (6).
Glycodelin-S also promotes human sperm binding to homologous zona
pellucida in the hemizona assay system (6). This intriguing combination
of biological activities led us to investigate further the
glycosylation of other components associated with HSP. By using fast
atom bombardment (FAB) and electrospray (ES) mass spectrometry to
screen HSP for novel glycoconjugates (7), we have made the surprising
discovery that this fluid is also rich in free oligosaccharides. The
only other human secretion known to contain a significant amount of
free oligosaccharides is human milk (reviewed in Refs. 8 and 9). More
than 90 distinct human milk oligosaccharides have been identified.
Their structural heterogeneity is derived primarily from differential
sialylation, fucosylation, branching, and polylactosamine chain
extension (8, 9).
Several significant biological activities have been ascribed to human
milk oligosaccharides. For example, many pathogens and bacterial toxins
recognize terminal carbohydrate sequences associated with these glycans
(reviewed in Ref. 10). Thus human milk oligosaccharides may block
infection in infants by interfering with crucial adhesion and binding
events essential for bacterial colonization and infection. A more
recent study suggests that human milk oligosaccharides inhibit the
binding of neutrophils activated with tumor necrosis factor to
endothelial cells in vitro (9) and thus may modulate inflammatory events in vivo.
In this paper, we report the structural characterization of several
families of free oligosaccharides present in HSP and show that they
share some of the structural characteristics of human milk
oligosaccharides, as well as having a number of unique features. The
great majority are heavily fucosylated and contain structural motifs
also present in the antennae of the N-linked
oligosaccharides of glycodelin-S. The potential impact of these unusual
free oligosaccharides on male reproductive function is discussed.
 |
EXPERIMENTAL PROCEDURES |
Purification of Seminal Plasma Fractions--
Seminal plasma
fractions were isolated from a range of healthy donors. Each sample was
purified individually. After liquefaction, an equal volume of methanol
was added to the semen, followed by sonication for 5 min and stirring
at room temperature for 20 min. Methanol and chloroform were
sequentially added to make the final composition (4:8:3) (v/v) in
chloroform/methanol/water (11). The sonication procedure was repeated
resulting in the majority of the proteins being precipitated. The
sample was then centrifuged at 800 × g for 15 min. The
supernatant was removed and saved. The precipitate was suspended in
one-half the original extraction volume of chloroform/methanol/water
(4:8:3), mixed, and centrifuged. The supernatant from each extraction
was pooled and mixed with deionized water to make the final composition
(4:8:5.6) in chloroform/methanol/water (11). The solution was then
gently vortexed and allowed to stand for 30 min at room temperature,
followed by centrifugation at 800 × g for 10 min. The
upper layer was carefully removed and dried on a rotary evaporator.
The residue after drying was resuspended in 50% aqueous methanol and
purified using a C18 reversed phase Sep-Pak (Waters
Associates) previously conditioned with methanol and 50% methanol
washes. The void fraction was collected and lyophilized. The total
hexose content of this fraction was compared with HSP using the phenol sulfuric acid assay (12). This fraction was dissolved in 1 ml of
deionized water and stored at 20 °C in preparation for mass spectrometric studies. Further purification was carried out on a
C18 Sep-Pak cartridge conditioned with 5-ml washes of
methanol, 5% acetic acid, and n-propyl alcohol
followed by a final 10-ml wash of 5% acetic acid. The free
oligosaccharides were eluted in 3 ml of 5% acetic acid.
Chemical Defucosylation--
Samples were incubated with 50 µl
of 48% hydrogen fluoride (Aldrich) at 0 °C for 48 h. The
reagent was removed by drying under a N2 stream.
Deuteroreduction of Glycans--
Glycans were deuteroreduced
using 200 µl of a 10 mg/ml solution of sodium borodeuteride in 2 M (aqueous) ammonium hydroxide. The reaction was allowed to
proceed at room temperature for 2 h and was terminated by the
dropwise addition of glacial acetic acid. The sample was dried under a
N2 stream and subjected to borate removal by repeated
drying in the presence of 10% acetic acid in methanol.
Exoglycosidase Digestions--
The defucosylated glycans were
incubated with the following enzymes: -L-fucosidase
(almond meal EC 3.2.1.111, Glyko) 4 microunits in 100 µl of 50 mM sodium formate, pH 5.0; -galactosidase/lactase (Escherichia coli overproducer EC 3.2.1.23, Roche Molecular Biochemicals) 15 units in 100 µl of 50 mM ammonium
formate and 50 mM potassium chloride pH 6.6;
-galactosidase (bovine testis, EC 3.2.1.23, Roche Molecular
Biochemicals) 10 milliunits in 100 µl of 50 mM ammonium
formate pH 4.6; and -N-acetylhexosaminidase (bovine
kidney, EC 3.2.1.30, Roche Molecular Biochemicals) 0.2 units in 100 µl of 50 mM ammonium formate buffer. The digestion with
the -galactosidase from E. coli overproducer was
performed for 48 h at 25 °C. All other enzyme digestions were
carried out at 37 °C for 24 h, with fresh enzyme added after
12 h. Each reaction was terminated by boiling for 2 min.
Periodate Cleavage--
Glycans were deuteroreduced as described
above. A solution of 35 mM sodium periodate in 100 mM ammonium acetate, pH 6.5, was prepared, and 100 µl
were added to the glycans. This mixture was wrapped in foil and
incubated at 0 °C overnight. The reaction was terminated by the
addition of 2-3 µl of ethylene glycol and incubated at room
temperature for 1 h. After drying under a N2 stream,
the products of periodate cleavage were reduced with 200 µl of a 10 mg/ml solution of sodium borohydride in 2 M ammonium hydroxide. This reaction was performed for 2 h, terminated by dropwise addition of glacial acetic acid, and dried under a
N2 stream. The sample was then subjected to borate removal,
permethylation, and Sep-Pak clean-up using an acetonitrile gradient as
described previously (7).
Methanolysis Experiments--
Permethylated glycans of D212 were
defucosylated by mild acid hydrolysis (0.5 M methanolic HCl
at room temperature). Aliquots of the methanolysis reaction were
monitored every 2 min by FAB-MS analysis. The free hydroxyl groups were
then remethylated using deuterated methyl iodide and subjected to
linkage analysis.
Trimethylsilylation of Purified Glycans--
After Sep-Pak
purification, methanolysis was performed on the sample. A solution of 1 M acetyl chloride in methanol was prepared by dissolving
100 µl of acetyl chloride in 1.3 ml of methanol. The glycans were
dissolved in 200 µl of this solution and incubated overnight at
80 °C. The reaction was terminated by drying under a N2
stream. The sample was re-N-acetylated by the sequential addition of 300 µl of methanol, 10 µl of pyridine, and 50 µl of acetic anhydride. After incubation for 15 min, the sample was dried
under a N2 stream. The sample was dissolved in 200 µl of Tri-sil-Z (Pierce) for 15 min before drying under a N2
stream. The tetramethylsilane-derivatized glycans were dissolved
in hexanes, vortexed, and centrifuged at 1000 rpm for 2 min. The
supernatant was carefully transferred to a new tube, dried under a
N2 stream, and stored at 70 °C in preparation for
GC-MS analysis.
Carbohydrate Standards for GC-MS Analysis--
Sophorose
(Glc 1-2Glc), laminaribose (Glc 1-3Glc), lactose (Gal 1-4Glc),
and Man 1-4Man were purchased from Sigma. Man 1-2Man, Gal 1-3Gal, Man 1-3Man, and Gal 1-4Gal were obtained from
Dextra Laboratories, Ltd. The H-disaccharide (Fuc 1-2Gal) was
supplied by Accurate Chemicals. These disaccharides were used to
determine the identity of the reducing hexose sugars
present in seminal plasma sample D212. These standards were first
deuteroreduced to label the reducing terminal sugars. This reaction was
carried out prior to permethylation and subsequent conversion to
partially methylated alditol acetates (13). GC-MS linkage analysis was performed on the carbohydrate standards. The retention times of the
reducing hexoses in these standards were compared with those of the
reducing terminal monosaccharides present in the sample. In separate
runs, the seminal plasma sample was spiked with 500 pmol of each
standard. Co-elution of reduced standards with the deuteroreduced
hexoses in D212 led to identification of the reducing terminal sugars
present in the seminal plasma-derived oligosaccharides.
Chemical Derivatization for FAB-MS, GC-MS, and CAD MS/MS
Analysis--
Glycans were permethylated using the sodium hydroxide
procedure and purified by Sep-Pak using a stepwise gradient of 0, 15, 35, 50, 75, and 100% aqueous acetonitrile as described previously (7).
Partially methylated alditol acetates were prepared from the
permethylated samples for GC-MS linkage analysis (13).
FAB-MS Analysis--
Fast atom bombardment-mass spectrometry was
carried out using a ZAB 2SE 2FPD double-focusing mass spectrometer
fitted with a cesium ion gun operated at 30 kV (7). Data were acquired and processed using VG Opus® software. Monothioglycerol was used as
the matrix, and all permethylated samples were dissolved in methanol
prior to loading (7).
GC-MS Analysis--
GC-MS analysis was carried out on a Fisons
Instruments MD800 device. Separation was achieved using a RTX-5 fused
silica capillary column (30 m × 0.25 mm internal diameter, Restek
Corp.) The sample was dissolved in hexanes prior to on-column loading
at 65 °C. The GC oven was held at 65 °C for 1 min before being
increased at a rate of 8-290 °C/min.
Other MS Analyses--
Electrospray mass spectrometry (MS) and
MS/MS were carried out using a Q-TOF (Micromass, UK) in positive ion
mode. The permethylated glycans were dissolved in methanol at a
concentration of ~10 pmol/µl. A sample flow rate of 10-30 nl/min
was produced when a potential of 1.5 kV was applied to the nanoflow
tip. The drying gas used was N2 and the collision gas was
argon, with the collision gas pressure maintained at 10 4
millibar. Collision energies varied depending on the size of the
carbohydrate, typically between 30 and 90eV.
 |
RESULTS |
Seminal Plasma Samples--
Seminal plasma samples obtained from
two donors were examined in this study. Detailed structural data are
reported for sample D212, and comparative data are provided for sample D112.
Structural Analysis Strategy--
The void volume fractions
resulting from Sep-Pak purification of the seminal plasma samples were
examined for their oligosaccharide content and composition. The void
fraction obtained after the initial reverse phase separation contained
70% of the total hexose content present in HSP. Scheme
1 summarizes the structural analysis strategy employed. Briefly, methylated or deuteromethylated derivatives were characterized by FAB-MS, ES-MS/MS, and linkage analysis before and
after deuteroreduction. These experiments were supplemented by similar
examination of the products of exo-glycosidase digestions and
hydrofluoric acid hydrolysates. The susceptibility of linear, deuteroreduced glycans to periodate oxidation was exploited to deduce
linkage features of the oligosaccharides. All samples were purified on
C18 Sep-Pak cartridges prior to analysis, and derivatized oligosaccharides were recovered in the 35 and 50% aqueous acetonitrile fractions, as outlined under "Experimental Procedures."
FAB-MS Screening of D212 Identifies Several Families of Fucosylated
Oligosaccharides--
Fig. 1 shows FAB
data acquired from sample D212 oligosaccharides after deuteroreduction
and permethylation. The upper and lower panels
correspond to the 35 and 50% aqueous acetonitrile fractions,
respectively. The low mass region of the 50% fraction (not shown) is
similar to the 35% fraction except that the signals are of lower
abundance. Assignments are given in Table
I. Notable features of the data are as
follows: (i) the major signals are attributed to fucosylated glycans,
the three most abundant being m/z 709, 842, and
913 that correspond to monofucosylated HexHexNAc, difucosylated
Hex2, and monofucosylated
Hex2HexNAc, respectively; relatives of these
glycans give the signals at m/z 494 (Hex2), 535 (HexHexNAc), 668 (FucHex2), 739 (Hex2HexNAc), 883 (Fuc2HexHexNAc), and 1087 (Fuc2Hex2HexNAc); (ii) two minor families of
glycans consisting of mono-, di-, and tri-fucosylated
Hex3HexNAc and difucosylated Hex2HexNAc2 were also identified in the 50%
aqueous acetonitrile fraction (signals m/z 1117, 1291, 1466, and 1333, respectively); (iii) the higher mass molecular
ions (m/z 1536, 1710, 1885, 2160, 2334, 2509, 2610, 2784, 3233, 3408, 3583, and 3757) have compositions (see Table I)
consistent with fucosylated glycans that have the Hex2HexNAc unit at their reducing ends and are extended by
up to four HexHexNAc repeats (i.e. polylactosamine type
structure); remarkably, the longer glycans carry up to seven fucose
residues; and (iv) minor A-type fragment ions were observed at
m/z 812 (Fuc2HexHexNAc+),
m/z 638 (FucHexHexNAc+), and
m/z 464 (HexHexNAc+) and were
accompanied by signals indicating methanol loss. Corroborative data for
these compositional assignments were obtained from deuteromethylated derivatives and from examination of permethylated non-reduced samples
(data not shown).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 1.
FAB mass spectra of the free glycans of D212
isolated from human seminal fluid. Glycans were deuteroreduced,
permethylated, and subjected to Sep-Pak clean-up. Upper
panel, 35% acetonitrile fraction; lower panel, 50%
acetonitrile fraction. The signals are assigned in Table I. All A-type
ions assigned in Table I are very minor but nevertheless are
reproducibly present in the various spectra acquired on this sample.
The assignment of the minor signal at m/z 393 is
corroborated by m/z 361 that corresponds to loss
of methanol.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Assignments of molecular ([M + Na]+) and fragment ions
detected in the FAB-MS of permethylated glycans derived from the 35 and
50% acetonitrile fractions of deuteroreduced D212 isolated from
human seminal fluid
Signals at m/z 361, 432, 606, and 780 correspond to methanol
loss from m/z 393, 464, 638, and 812, respectively.
|
|
Linkage Analysis of the Free Glycans Isolated from Seminal Plasma
Fraction D212 Reveals the Presence of Glucose as the Major Reducing
Sugar--
Deuteroreduction prior to linkage analysis allowed the
reducing terminal sugars to be detected in the linkage data (Table II). From these experiments it was clear
that the main reducing monosaccharides associated with the HSP
oligosaccharides are 4-linked glucose and its 3,4-linked counterpart
(Fig. 2). Signals corresponding to
3-linked and 2-linked glucose as reducing terminal sugars were observed, although the latter sugar was found to be present only in
minor amounts (Fig. 2). Other reducing end monosaccharides found in the
seminal plasma glycans include 4-linked and 3,4-linked GlcNAc.
Carbohydrate standards were used to distinguish between the different
hexose residues.
View this table:
[in this window]
[in a new window]
|
Table II
GC-MS analysis of the partially methylated alditol acetates obtained
from the free glycans of seminal plasma fraction D212
These were deuteroreduced prior to permethylation in order to identify
the reducing terminal residues. The deuteroreduced 35% acetonitrile
fraction from Sep-Pak purification of permethylated glycans was
hydrolyzed, reduced, acetylated, and analyzed by GC-MS. Only the linked
deuteroreduced residues are shown.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
GC-MS analysis of the free glycans of D212
isolated from human seminal plasma. Deuteroreduction was carried
out prior to linkage analysis. A, total ion chromatogram of
D212 demonstrating the region where the deuteroreduced linked-glucose
residues elute (see Table II), the peaks eluting at 17.20, 18.75, and
19.08 min are terminal Fuc, terminal Glc, and terminal Gal,
respectively. The electron impact mass spectra of the peaks are eluting
in the GC chromatogram at the positions of deuteroreduced 4-linked
glucose (B) and deuteroreduced 3,4-linked glucose
(C).
|
|
Linkage analysis data for sample D212 with no prior deuteroreduction
are summarized in Table III. Key features
of these data are as follows: (i) fucose, galactose, and GlcNAc are the
major terminal sugars present, whereas GalNAc was only observed as a minor terminal component of the seminal plasma mixture and was not
found in any linked form; (ii) a reduction in the signals corresponding
to 2-linked Gal and 3,4-linked GlcNAc was observed after aqueous HF
defucosylation and was coupled to an increase in terminal galactose and
4-linked GlcNAc; and (iii) minor amounts of differentially linked
mannoses were observed that could be derived from N-glycans
present in HSP. Additional information acquired from the analysis of
trimethylsilyl ester methylglycosides of the total glycan population
revealed that myoinositol was also present in high abundance (data not
shown).
View this table:
[in this window]
[in a new window]
|
Table III
Data from linkage analysis of the partially methylated alditol acetates
obtained from the permethylated seminal plasma fraction D212
The 35% acetonitrile fraction from Sep-Pak purification of
permethylated glycans was hydrolyzed, reduced, acetylated, and analyzed
by GC-MS. The elution times for the various monosaccharides and their
diagnostic fragment ions are shown. Additionally, 2,3-linked galactose
was observed as a minor component of the 50% acetonitrile fraction.
|
|
Characterization of Fucosylated Structures: Q-TOF MS/MS Analysis of
the Permethylated Free Oligosaccharides Present in Deuteroreduced
Oligosaccharides--
[M + Na]+ molecular ions in the
mass range m/z 668-1710 were subjected to low
energy, CAD MS/MS in order to define the sequences and, in some cases,
the linkages of the glycans present in seminal fluid. The MS/MS spectra
and fragmentation pathways for FucHex2 (m/z 668), FucHexHexNAc
(m/z 709), Fuc2Hex2
(m/z 842), Fuc2HexHexNAc (m/z 883), FucHex2HexNAc
(m/z 913),
Fuc2Hex2HexNAc (m/z
1087), Fuc2Hex3HexNAc2
(m/z 1536), and
Fuc3Hex3HexNAc2
(m/z 1710) are shown in Figs.
3 and
4.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
CAD MS/MS spectra of the [M + Na]+ molecular ions of m/z
668 (A), m/z
709 (B), m/z
842 (C), and m/z
883 (D) of the permethylated glycans derived
from the 35% acetonitrile fraction of deuteroreduced D212 isolated
from human seminal plasma. The fragment ion
m/z 489 in the MS/MS spectrum of molecular ion
m/z 883 is a result of water loss from
m/z 507. Other fragment ions are assigned in the
inset.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
CAD MS/MS spectra of the [M + Na]+ molecular ions of m/z
913 (A), m/z
1087 (B), m/z
1536 (C), and m/z
1710 (D) of the permethylated free glycans
derived from the 50% acetonitrile fraction of deuteroreduced D212
isolated from human seminal plasma. The fragment ion
m/z 633 in A arises from
-elimination of the fucose residue (m/z 707)
followed by loss of the upper half of the GlcNAc residue via a ring
cleavage mechanism (14). The fragment ions m/z
807 and 1430 in B and D, respectively, are
similarly derived. The fragment ion m/z 415 in
A results from the loss of a terminal galactose from
m/z 633. The insets shown in
C and D correspond to the major structure
identified in each case. Signals attributable to the minor structure in
C are explained in the text. Signals indicative of
structural isomers of the inset shown in D are
present at m/z 1073 (a fucose higher than
m/z 899), m/z 867 (a fucose
higher than m/z 693), and
m/z 660 (a fucose lower than
m/z 834). These signals indicate that a
significant minority of the sample carries two fucoses attached to the
reducing end trisaccharide.
|
|
Cleavage on either side of the glycosidic oxygen provided information
that was useful for sequence assignment, and these signals were
prevalent in all MS/MS spectra. Cross-ring fragments determining linkage position were generally weaker, although they were observed in
the MS/MS spectra of lower mass components; for example, the MS/MS
spectrum of m/z 913 contains a signal
m/z 329, confirming the 4-linkage between
terminal Gal and sub-terminal GlcNAc.
Previous mass spectrometric analyses have shown that when a substituent
is 3-linked to a HexNAc unit, it is readily eliminated (14). A large
signal corresponding to elimination of fucose from GlcNAc
(m/z 503) was observed following CAD MS/MS
analysis of the mono-fucosylated trisaccharide FucHexHexNAc (Fig.
3B), indicating that the fucose residue was originally
3-linked in this case. CAD MS/MS analysis also on mono-fucosylated
Hex2HexNAc (m/z 913, Fig.
4A) revealed that the fucose residue is 1-3 linked to
the GlcNAc, whereas the second fucose is preferentially attached to the
terminal galactose residue in the difucosylated form
(m/z 1087, Fig. 4B).
The spectrum of m/z 1536 (Fuc2Hex3HexNAc2) (Fig.
4C) indicates that that the majority of this component is
fucosylated at each of the GlcNAc residues as shown in the
inset. Thus, major signals are observed at
m/z 660 and 899 that correspond to
mono-fucosylated non-reducing end and mono-fucosylated reducing end
structures, respectively, resulting from cleavage at the GlcNAc-Gal
glycosidic linkage in the center of the backbone (see Fig.
4C). The very minor signals at m/z 834 and 725 are the corresponding fragment ions for an isomeric structure
in which the two fucose residues are attached to the non-reducing
disaccharide to give a Lewisy epitope. A signal
corresponding to -elimination of fucose from the major fragment ion
m/z 899 (m/z 693), together
with the presence of an ion corresponding to non-reducing Hex
(m/z 259), provide confirmatory evidence for the
majority of fucose being linked to the two GlcNAc residues in
Lewisx arrangements. Interpreting the MS/MS spectrum of
m/z 1710 (Fuc3Hex3HexNAc2) (Fig.
4D) in a similar manner allows us to arrive at the
conclusion that the majority of the glycans with this composition carry
fucose on the non-reducing galactose and the adjacent GlcNAc residue, with the third fucose being attached to the other GlcNAc residue (see
inset in Fig. 4D). Conversely, a portion of the
glycans have a fucose residue attached at each GlcNAc, with the third
fucose being located on either the 3-linked galactose or the reducing terminal glucose (see legend to Fig. 4D).
Comparison of MS/MS data with that derived from authentic material
indicated that the molecular ions m/z 668, 709, 842, and 883 likely correspond to 3'-fucosyllactose,
LewisX, difucosyllactose, and Lewisy,
respectively (data not shown).
Confirmation of Inter-saccharide Linkages Using Methanolysis
and Periodate Cleavage--
Corroborative evidence for the positions
of attachment of the fucose residues was provided by mild methanolysis
experiments. Permethylated glycans of D212 were defucosylated using
mild acid hydrolysis (0.5 M methanolic HCl at room
temperature) and monitored by FAB-MS. The free hydroxyl groups were
re-methylated using deuterated methyl iodide, and linkage analysis was
carried out to deduce where the fucoses had been attached. This
structural feature can be identified by a characteristic mass shift of
the fragment ion in the electron impact mass spectrum. Additional
signals at 121 and 165 Da were observed in the electron impact mass
spectrum of terminal Gal (data not shown), verifying that fucose had
been attached previously at the 2-position of galactose. Comparison of
linkage data before and after methanolysis indicates that the loss of
fucose from 3,4-linked glucose is accompanied by an increase in
4-linked glucose. The EI-MS data for 4-linked Glc and 4-linked GlcNAc
unambiguously confirm that fucose is 3-linked to these sugars in both
cases based upon the presence of a new signal at m/z 236. No new signals were observed from
the EI-MS of 3-linked Glc and 2-linked Glc, indicating that these
components were not originally fucosylated.
Mild periodate oxidation will cleave the vicinal hydroxyl groups
present in linear sugar structures. Therefore the reducing sugars of
deuteroreduced glycans are susceptible to this reagent. Purified
glycans were subjected to periodate oxidation (35 mM concentration) followed by reduction, permethylation, and Sep-Pak clean-up in preparation for FAB-MS analysis. Fast atom bombardment of
the periodate products resulted in new signals representing loss of the
relevant substituents, therefore confirming linkage positions.
Significant peaks at m/z 780 and 954 (from
m/z 913 and 1087, respectively) indicated that
the deuteroreduced glucose in this glycan family was not 2-linked and
was instead 3- or 4-linked.
Exoglycosidase and Chemical Digestions--
To establish the
anomeric configurations of the glycan residues present in D212, a
series of exoglycosidases were employed. The -linkage of the fucose
residues was determined after digestion of the seminal plasma glycans
with -L-fucosidase prior to permethylation and FAB-MS analyses.
HF-treated glycans were further digested with lactase resulting in a
marked decrease in m/z 477 (Hex2),
substantiating the presence of lactose. Subsequent -galactosidase
and -N-acetylhexosaminidase digests confirmed the
-linkages of galactose and GlcNAc residues.
Comparison of D212 with Seminal Plasma Samples Obtained from
Different Donors--
FAB-MS strategies were employed on sample D112,
revealing a similar glycan profile to that of D212 but with inherently
lower levels of fucosylation. The absence of molecular ions
m/z 842, 883, 1087, 1710, and 1885 in the FAB-MS
data and of signals in the linkage data corresponding to 2-linked
galactose would imply that the gene for -1,2-fucosyltransferase is
not expressed in the reproductive glands of this individual.
Structural Conclusions--
Taking into consideration the FAB-MS,
linkage, CAD MS/MS, periodate, methanolysis, and exoglycosidase data,
we conclude that human seminal plasma contains several families of
highly fucosylated free glycans, with the sequences shown in Fig.
5. The main features are as follows. (i)
These glycans are composed of differing backbones with the most
abundant consisting of either lactose-based or novel Gal 1-4GlcNAc 1-3/4Glc sequences decorated with varying levels of
fucosylation. (ii) The fucoses are attached to the Gal and GlcNAc
residues giving both Lewisx and Lewisy
terminated structures. (iii) The largest glycan observed is an octadecamer with the composition
Fuc7Hex6HexNAc5
(m/z 3757, Fig. 1B and Table I)
containing the Gal 1-4GlcNAc 1-3/4Glc sequence at the reducing
terminal extended by four N-acetyllactosamine repeats, with
an overall level of fucosylation consistent with substitution of each
GlcNAc residue and both terminal sugars.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 5.
Proposed structures of the major free
oligosaccharides present in deuteroreduced D212 isolated from human
seminal plasma. The ambiguity with respect to the linkage of the
reducing end glucose in structures that are not fucosylated at this
sugar arises from the observation of both 3- and 4-linked glucoses in
the linkage analysis. Structures IXa and Xa are
the major constituents giving m/z 1536 and 1710, respectively. Structure Xb is the most likely
Lewisx-containing isomer of structure Xa,
although the observation of a trace amount of 2,3-Gal in the linkage
analysis suggests that a tiny portion of the sample probably carries
the third fucose on the central galactose rather than the reducing-end
glucose. Similarly, we have not ruled out the possibility of the
presence of the analogous isomer of structure XI
(m/z 1885) in which the central galactose is
fucosylated.
|
|
 |
DISCUSSION |
To our knowledge this study is the first revealing the existence
of free oligosaccharides in HSP. Thus both human milk and HSP are
secretions that contain free oligosaccharides. However, there are
several significant differences between milk and HSP oligosaccharides
revealed by the current structural analyses: (i) the concentration of
free oligosaccharides is greater in human milk than HSP (5-8
versus 0.3-0.4 mg/ml) (9); (ii) sialylated oligosaccharides
are very minor components in HSP (data not shown) but represent
25-30% of the total human milk glycans (15); (iii) the majority of
complex HSP oligosaccharides are fucosylated; (iv) a subset of HSP
oligosaccharides express the reducing end sequence (GlcNAc 1-3/4Glc)
not reported in human milk oligosaccharides; (v) HSP oligosaccharides
exclusively express type 2 (Gal 1-4GlcNAc) but not the type 1 sequences (Gal 1-3GlcNAc) that predominate in human milk
oligosaccharides (9); and (vi) the structural diversity of human milk
oligosaccharides greatly exceeds that of HSP oligosaccharides (16).
The pathway for the synthesis of HSP and human milk oligosaccharides
may share some common features, however. -Galactosyltransferase and
-fucosyltransferase activities associated with free oligosaccharide synthesis are present in human milk (17, 18). Similar enzymatic activities are also present in HSP (19, 20). The properties of the
HSP-associated galactosyltransferase include the following: (i)
sensitivity to -lactalbumin (20), a modifier protein in mammalian
milk (21) that shifts the substrate acceptor specificity of breast milk
galactosyltransferase from GlcNAc to Glc (22); (ii) origin primarily in
the prostate and epididymis (19, 20); and (iii) androgen dependence
(20). A possible functional linkage is the observation that human sperm
penetration through cervical mucus is positively correlated with this
HSP-associated -galactosyltransferase activity (23).
Another interesting finding is that the level of HSP-associated
-fucosyltransferase activity greatly exceeds the
-galactosyltransferase activity in vitro (24). This
observation is consistent with the content of fucosylated
oligosaccharides present in HSP. This -fucosyltransferase activity
originates primarily in the prostate and is also
androgen-dependent (25).
There is currently no evidence suggesting that other mammalian species
express free oligosaccharides in their seminal plasma. However, there
are data supporting the existence of glycosyltransferases and
associated biosynthetic proteins in rat seminal plasma. Both a
substantial -galactosyltransferase activity and an -lactalbumin homologue are present in rat seminal plasma (26). Rat seminal plasma
also contains very substantial amounts of -fucosyltransferase activity (27). These enzymes are postulated to function in the modification of sperm-surface glycoproteins (27), but based on the
current evidence such enzymes could be involved in free oligosaccharide synthesis.
The function of HSP oligosaccharides in the male and/or the female
reproductive systems is unknown. Because humans do not inject semen
directly into the uterus, sperm and other seminal plasma components
must traverse the cervical mucin plug to enter this organ (reviewed in
Ref. 28). It may be easier for smaller components like free
oligosaccharides to move through this plug at midcycle to influence
events within the uterus and the oviduct. Support of sperm function in
the uterus and oviduct would certainly be physiologically relevant. Of
the several million sperm present in human semen, at most a few hundred
arrive in the ampulla of the oviduct where fertilization takes place
(reviewed in Ref. 1). Indeed, a very great mystery is how natural
fertilization occurs in the presence of such low concentrations of
sperm compared with those required for successful in
vitro fertilization or sperm binding assays. The logical reason is
that male and female factors operating within the vagina and oviduct
facilitate this process.
Possible supportive effects of free oligosaccharides on sperm function
include the following: (i) increasing sperm longevity by delaying
hyperactivation; (ii) modifying sperm motion parameters that increase
fertility, especially progressive motility; and (iii) promoting sperm
binding to eggs.
Human sperm display decreased hyperactivation and increased
progressive motility following exposure to human cervical mucins in vitro (29). The major O-glycans associated
with human midcycle cervical mucins are terminated with
Lewisx and Lewisy sequences (30), as are HSP
oligosaccharides. Human sperm binding to the zona pellucida is
increased by 20% in the hemizona assay in the presence of fucose (1 mg/ml) but not other monosaccharides (31). Similarly, glycodelin-S, a
HSP glycoprotein also terminated with Lewisx and
Lewisy sequences, increases sperm binding in the hemizona
assay by 50% at physiological concentrations (6). The expression of
fucosylated sequences on free oligosaccharides, mucins, and
glycoproteins may promote sperm-egg binding in the human oviduct.
The oligosaccharides associated with HSP could also play a pivotal role
in blocking immune/inflammatory cell reactions in the male and female
reproductive systems. Except for sperm, leukocytes are the most
prevalent cell type present in HSP from fertile males. These leukocytes
are primarily neutrophils, with lower numbers of monocytes and T cells
(reviewed in Ref. 32). Leukocytospermia is a condition characterized by
excessive numbers of leukocytes in semen (reviewed in Ref. 33).
Elevation in leukocytes above a certain threshold is associated with
male infertility (32). There is also a very profound influx of
leukocytes into the vagina and cervix following intercourse, an event
referred to as the leukocyte reaction (34). The majority of the
invasive cells are neutrophils, with minor amounts of natural killer
cells and monocytes (34). Human sperm express carbohydrate sequences
that are recognized by natural killer cells (35), so they are likely protected from this type of lymphocyte. However, the factors protecting sperm from other immune and inflammatory cell types in semen and the
uterus are not very well defined.
There is some good evidence that prostate vesicles (prostasomes)
present in HSP scavenge reactive oxygen species produced by neutrophils
and monocytes (36). Therefore, prostasomes may protect sperm from the
toxic by-products of neutrophil metabolism. Other investigators
suggest that prostaglandins (PGE2 and 19-hydroxy-PGE) present in HSP play a crucial role in the suppression of leukocytes (3). However, incubation of the neutrophil model cell line U937 with a
seminal plasma fraction enriched in PGE2 and 19-hydroxy-PGE had no effect on the release of the immunosuppressive cytokine interleukin-10 at the highest concentration tested (0.1% of the seminal plasma concentration) (37). By contrast, incubation of U937
cells with media containing HSP diluted to the same extent induces
substantial interleukin-10 release from U937 cells (37). This result
implies that other components within HSP are likely responsible for the
major suppressive effect of this secretion. One factor implicated in
this immunomodulation is glycodelin-S, a glycoprotein that shares
terminal Lewisx and Lewisy sequences with the
HSP oligosaccharides (6).
Human milk oligosaccharides block the binding of many pathogens or
their toxins to colonic epithelial cells in vitro (reviewed in Refs. 9 and 10). Several of these crucial interactions are inhibited
by fucosylated oligosaccharides present in this secretion. HSP
oligosaccharides could also block infection with pathogens responsible
for urogenital tract infections. Fucosylated glycans have been
implicated in infection with human T-cell lymphotrophic virus, type I,
and human immunodeficiency virus (38, 39). Additional study will be
required to determine whether HSP oligosaccharides confer any
protective effect against pathogens in the male and/or female
reproductive systems.
In summary, free oligosaccharides of highly restricted sequence
heterogeneity are expressed in the HSP of fertile men. The presence of
a predominant modification of the complex glycans (fucosylation)
suggests potential functional significance especially when linked to
previous data collected in the human model. Further investigation will
be required to define the precise physiological roles of these free
oligosaccharides in human reproduction.
 |
FOOTNOTES |
*
This work was supported by the Biotechnology and Biological
Sciences Research Council and the Wellcome Trust (to A. D. and H. R. M.), National Institutes of Health Grant HD35652 (to G. F.
C.), and Jeffress Research Grant J-584 (to M. S. P.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence may be addressed. Tel.:
44-207-225-5219; Fax: 44-207-225-0458; E-mail: h.morris@ic.ac.uk.
To whom correspondence may be addressed. Tel.:
44-207-225-5219; Fax: 44-207-225-0458; E-mail: a.dell@ic.ac.uk.
**
To whom correspondence may be addressed. Tel.: 757-446-5653; Fax:
757-624-2270; E-mail: clarkgf@evms.edu.
Published, JBC Papers in Press, June 12, 2002, DOI 10.1074/jbc.M205152200
 |
ABBREVIATIONS |
The abbreviations used are:
HSP, human seminal
plasma;
FAB-MS, fast atom bombardment mass spectrometry;
ES, electrospray;
GC, gas chromatography;
MS, mass spectrometry;
Q-TOF, quadrupole orthogonal acceleration time of flight mass spectrometer;
CAD, collisionally activated decomposition;
PG, prostaglandin.
 |
REFERENCES |
| 1.
|
Setchell, B. P.,
and Brooks, D. E.
(1980)
in
Perspectives in Male Reproduction
(Knobil, E.
, and Neill, J. D., eds)
, pp. 753-856, Raven Press, Ltd., New York
|
| 2.
|
Sobrero, A. J.,
and MacLeod, J. K.
(1962)
Fertil. Steril.
13,
184-189[Medline]
[Order article via Infotrieve]
|
| 3.
|
Kelly, R. W.,
and Critchley, H. O.
(1997)
Hum. Reprod.
12,
2200-2207[Abstract]
|
| 4.
|
Robertson, S. A.,
and Sharkey, D. J.
(2001)
Semin. Immunol.
13,
243-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Bolton, A. E.,
Pockley, A. G.,
Clough, K. J.,
Mowles, E. A.,
Stoker, R. J.,
Westwood, O. M.,
and Chapman, M. G.
(1987)
Lancet
1,
593-595[Medline]
[Order article via Infotrieve]
|
| 6.
|
Morris, H. R.,
Dell, A.,
Easton, R. L.,
Panico, M.,
Koistinen, H.,
Koistinen, R.,
Oehninger, S.,
Patankar, M. S.,
Seppala, M.,
and Clark, G. F.
(1996)
J. Biol. Chem.
271,
32159-32167[Abstract/Free Full Text]
|
| 7.
|
Dell, A.,
Khoo, K.-H.,
Panico, M.,
McDowell, R. A.,
Etienne, A. T.,
Reason, A. J.,
and Morris, H. R.
(1993)
in
Glycobiology: A Practical Approach
(Fukuda, M.
, and Kobata, A., eds)
, pp. 187-222, Oxford University Press, Oxford
|
| 8.
|
Newburg, D. S.,
and Neubauer, S. H.
(1995)
in
Handbook of Milk Composition
(Jenson, R. G., ed)
, pp. 273-349, Academic Press, San Diego
|
| 9.
|
Kunz, C.,
Rudloff, S.,
Baier, W.,
Klein, N.,
and Strobel, S.
(2000)
Annu. Rev. Nutr.
20,
699-722[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Newburg, D. S.
(1999)
Curr. Med. Chem.
6,
117-127[Medline]
[Order article via Infotrieve]
|
| 11.
|
Svennerholm, L.,
and Fredman, P.
(1980)
Biochim. Biophys. Acta
617,
97-109[Medline]
[Order article via Infotrieve]
|
| 12.
|
Dubois, M.,
Gilles, K. A.,
Hamilton, J. K.,
Rebers, P. A.,
and Smith, F.
(1956)
Anal. Chem.
28,
350-356[CrossRef]
|
| 13.
|
Albersheim, P.,
Nevins, D. J.,
English, P. D.,
and Karr, A.
(1967)
Carbohydr. Res.
5,
340-345[CrossRef]
|
| 14.
|
Dell, A.
(1987)
Adv. Carbohydr. Chem. Biochem.
45,
19-72[Medline]
[Order article via Infotrieve]
|
| 15.
|
Smith, D. F.,
Zopf, D. A.,
and Ginsburg, V.
(1978)
Anal. Biochem.
85,
602-608[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Stahl, B.,
Thurl, S.,
Zeng, J.,
Karas, M.,
Hillenkamp, F.,
Steup, M.,
and Sawatzki, G.
(1994)
Anal. Biochem.
223,
218-226[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Nagasawa, T.,
Kiyosawa, I.,
and Tanahashi, N.
(1971)
J. Dairy Sci.
54,
835-841[Abstract/Free Full Text]
|
| 18.
|
Grollman, E. F.,
Kobata, A.,
and Ginsburg, V.
(1969)
J. Clin. Invest.
48,
1489-1494[Medline]
[Order article via Infotrieve]
|
| 19.
|
Tadolini, B.,
Wilson, T. J.,
Reddy, P. R.,
and Williams-Ashman, H. G.
(1976)
Adv. Enzyme Regul.
15,
319-336[Medline]
[Order article via Infotrieve]
|
| 20.
|
Ross, P.,
Vigneault, N.,
Provencher, S.,
Potier, M.,
and Roberts, K. D.
(1993)
J. Reprod. Fertil.
98,
129-137[Abstract/Free Full Text]
|
| 21.
|
Brodbeck, U.,
and Ebner, K. E.
(1966)
J. Biol. Chem.
241,
762-764[Abstract/Free Full Text]
|
| 22.
|
Brew, K.,
Vanaman, T. C.,
and Hill, R. L.
(1968)
Proc. Natl. Acad. Sci. U. S. A.
59,
491-497[Free Full Text]
|
| 23.
|
Ronquist, G.,
Stegmayr, B.,
Andren, C.,
and Wikstrom, K.
(1985)
Urol. Int.
40,
269-273[Medline]
[Order article via Infotrieve]
|
| 24.
|
Ronquist, G.
(1987)
Urol. Int.
42,
143-147[Medline]
[Order article via Infotrieve]
|
| 25.
|
Ronquist, G.,
and Stegmayr, B.
(1984)
Urol. Res.
12,
243-247[Medline]
[Order article via Infotrieve]
|
| 26.
|
Hamilton, D. W.
(1981)
Biol. Reprod.
25,
385-392[Abstract]
|
| 27.
|
Tulsiani, D. R.,
Orgebin-Crist, M. C.,
and Skudlarek, M. D.
(1998)
J. Reprod. Fertil.
53 (suppl.),
85-97
|
| 28.
|
Gipson, I. K.
(2001)
Front. Biosci.
6,
D1245-D1255[Medline]
[Order article via Infotrieve]
|
| 29.
|
Eriksen, G. V.,
Carlstedt, I.,
Uldbjerg, N.,
and Ernst, E.
(1998)
Fertil. Steril.
70,
350-354[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Yurewicz, E. C.,
Matsuura, F.,
and Moghissi, K. S.
(1982)
J. Biol. Chem.
257,
2314-2322[Abstract/Free Full Text]
|
| 31.
|
Oehninger, S.,
Acosta, A.,
and Hodgen, G. D.
(1990)
Fertil. Steril.
53,
143-149[Medline]
[Order article via Infotrieve]
|
| 32.
|
Wolff, H.
(1995)
Fertil. Steril.
63,
1143-1157[Medline]
[Order article via Infotrieve]
|
| 33.
|
Aitken, R. J.,
and Baker, H. W.
(1995)
Hum. Reprod.
10,
1736-1739[Free Full Text]
|
| 34.
|
Thompson, L. A.,
Barratt, C. L.,
Bolton, A. E.,
and Cooke, I. D.
(1992)
Am. J. Reprod. Immunol.
28,
85-89
|
| 35.
|
Patankar, M. S.,
Ozgur, K.,
Oehninger, S.,
Dell, A.,
Morris, H.,
Seppala, M.,
and Clark, G. F.
(1997)
Mol. Hum. Reprod.
3,
501-505[Abstract/Free Full Text]
|
| 36.
|
Saez, F.,
Motta, C.,
Boucher, D.,
and Grizard, G.
(1998)
Mol. Hum. Reprod.
4,
667-672[Abstract/Free Full Text]
|
| 37.
|
Denison, F. C.,
Grant, V. E.,
Calder, A. A.,
and Kelly, R. W.
(1999)
Mol. Hum. Reprod.
5,
220-226[Abstract/Free Full Text]
|
| 38.
|
Zacharopoulos, V. R.,
and Phillips, D. M.
(1997)
Microb. Pathog.
23,
225-233[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Ushijima, H.,
Schroder, H. C.,
Poznanovic, S.,
Matthes, E.,
and Muller, W. E.
(1992)
Res. Virol.
143,
97-99[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Sabatte, A. Ceballos, S. Raiden, M. Vermeulen, K. Nahmod, J. Maggini, G. Salamone, H. Salomon, S. Amigorena, and J. Geffner
Human Seminal Plasma Abrogates the Capture and Transmission of Human Immunodeficiency Virus Type 1 to CD4+ T Cells Mediated by DC-SIGN
J. Virol.,
December 15, 2007;
81(24):
13723 - 13734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-C. Pang, B. Tissot, E. Z. Drobnis, P. Sutovsky, H. R. Morris, G. F. Clark, and A. Dell
Expression of Bisecting Type and Lewisx/Lewisy Terminated N-Glycans on Human Sperm
J. Biol. Chem.,
December 14, 2007;
282(50):
36593 - 36602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Parry, N.-K. Wong, R. L Easton, M. Panico, S. M Haslam, H. R Morris, P. Anderson, K. L Klotz, J. C Herr, A. B Diekman, et al.
The sperm agglutination antigen-1 (SAGA-1) glycoforms of CD52 are O-glycosylated
Glycobiology,
October 1, 2007;
17(10):
1120 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|